173 related articles for article (PubMed ID: 17394445)
1. Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis?
Preiss DJ; Sattar N
Int J Clin Pract; 2007 Apr; 61(4):697-701. PubMed ID: 17394445
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of endothelial and monocyte redox-sensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent.
Kunsch C; Luchoomun J; Grey JY; Olliff LK; Saint LB; Arrendale RF; Wasserman MA; Saxena U; Medford RM
J Pharmacol Exp Ther; 2004 Mar; 308(3):820-9. PubMed ID: 14617690
[TBL] [Abstract][Full Text] [Related]
3. AGI-1067, a novel vascular protectant, anti-inflammatory drug and mild antiplatelet agent for treatment of atherosclerosis.
Serebruany VL; Malinin A; Eisert C; Ong S
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):635-41. PubMed ID: 17605642
[TBL] [Abstract][Full Text] [Related]
4. AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent.
Sundell CL; Somers PK; Meng CQ; Hoong LK; Suen KL; Hill RR; Landers LK; Chapman A; Butteiger D; Jones M; Edwards D; Daugherty A; Wasserman MA; Alexander RW; Medford RM; Saxena U
J Pharmacol Exp Ther; 2003 Jun; 305(3):1116-23. PubMed ID: 12626663
[TBL] [Abstract][Full Text] [Related]
5. Vascular protectants for the treatment of atherosclerosis.
Tardif JC; Grégoire J; Lavoie MA; L'Allier PL
Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):385-92. PubMed ID: 15030266
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis.
Nahrendorf M; Jaffer FA; Kelly KA; Sosnovik DE; Aikawa E; Libby P; Weissleder R
Circulation; 2006 Oct; 114(14):1504-11. PubMed ID: 17000904
[TBL] [Abstract][Full Text] [Related]
7. AGI-1067: a novel vascular protectant for prevention of restenosis.
Franks AM; Gardner SF
Ann Pharmacother; 2006 Jan; 40(1):66-73. PubMed ID: 16303986
[TBL] [Abstract][Full Text] [Related]
8. Endothelial CD81 is a marker of early human atherosclerotic plaques and facilitates monocyte adhesion.
Rohlena J; Volger OL; van Buul JD; Hekking LH; van Gils JM; Bonta PI; Fontijn RD; Post JA; Hordijk PL; Horrevoets AJ
Cardiovasc Res; 2009 Jan; 81(1):187-96. PubMed ID: 18805782
[TBL] [Abstract][Full Text] [Related]
9. Gypenoside XLIX, a naturally occurring PPAR-alpha activator, inhibits cytokine-induced vascular cell adhesion molecule-1 expression and activity in human endothelial cells.
Huang TH; Tran VH; Roufogalis BD; Li Y
Eur J Pharmacol; 2007 Jun; 565(1-3):158-65. PubMed ID: 17434475
[TBL] [Abstract][Full Text] [Related]
10. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.
Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E
J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138
[TBL] [Abstract][Full Text] [Related]
11. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
Jacob S; Laury-Kleintop L; Lanza-Jacoby S
J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
[TBL] [Abstract][Full Text] [Related]
12. Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation.
Zapolska-Downar D; Naruszewicz M
J Physiol Pharmacol; 2009 Jun; 60(2):123-31. PubMed ID: 19617655
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of lacrimal gland inflammation by oral administration of K-13182 in Sjögren's syndrome model mice.
Nishiyama T; Mishima K; Obara K; Inoue H; Doi T; Kondo S; Saka M; Tabunoki Y; Hattori Y; Kodama T; Tsubota K; Saito I
Clin Exp Immunol; 2007 Sep; 149(3):586-95. PubMed ID: 17614971
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral gene transfer of viral interleukin-10 protects cerebrovascular impairment induced by lysophosphatidylcholine.
Kang H; Yang PY; Rui YC
Eur J Pharmacol; 2008 Feb; 580(1-2):175-81. PubMed ID: 18154952
[TBL] [Abstract][Full Text] [Related]
15. Probucol [4,4'-[(1-methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl)phenol]] inhibits compensatory remodeling and promotes lumen loss associated with atherosclerosis in apolipoprotein E-deficient mice.
Wu BJ; Di Girolamo N; Beck K; Hanratty CG; Choy K; Hou JY; Ward MR; Stocker R
J Pharmacol Exp Ther; 2007 May; 321(2):477-84. PubMed ID: 17293560
[TBL] [Abstract][Full Text] [Related]
16. Cholestin (Monascus purpureus rice) inhibits homocysteine-induced reactive oxygen species generation, nuclear factor-kappaB activation, and vascular cell adhesion molecule-1 expression in human aortic endothelial cells.
Lin CP; Chen YH; Chen JW; Leu HB; Liu TZ; Liu PL; Huang SL
J Biomed Sci; 2008 Mar; 15(2):183-96. PubMed ID: 17906965
[TBL] [Abstract][Full Text] [Related]
17. Vascular adhesion molecules in atherosclerosis.
Galkina E; Ley K
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2292-301. PubMed ID: 17673705
[TBL] [Abstract][Full Text] [Related]
18. Bisacurone inhibits adhesion of inflammatory monocytes or cancer cells to endothelial cells through down-regulation of VCAM-1 expression.
Sun DI; Nizamutdinova IT; Kim YM; Cai XF; Lee JJ; Kang SS; Kim YS; Kang KM; Chai GY; Chang KC; Kim HJ
Int Immunopharmacol; 2008 Sep; 8(9):1272-81. PubMed ID: 18602074
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells.
Pandolfi A; Di Pietro N; Sirolli V; Giardinelli A; Di Silvestre S; Amoroso L; Di Tomo P; Capani F; Consoli A; Bonomini M
J Cell Physiol; 2007 Dec; 213(3):699-709. PubMed ID: 17516566
[TBL] [Abstract][Full Text] [Related]
20. Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis.
Peter K; Weirich U; Nordt TK; Ruef J; Bode C
Thromb Haemost; 1999 Sep; 82 Suppl 1():38-43. PubMed ID: 10695484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
